1008344

Halo Pharmaceutical, Inc. d/b/a Cambrex Whippany — FEI 2211084

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 20, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Whippany, NJ (United States)